StockData
Personalis, Inc. logo

Personalis, Inc. (PSNL) stock

PSNLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30345% above fair value
$14.80+0.00 (0.00%)

Close on Nov 17, 2026Market cap $1.58BP/E –Yield –

Personalis pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Personalis

Personalis has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Personalis figures

See a number that looks wrong?